Astrana Health (NASDAQ:ASTH) Stock Price Down 2.7% – Here’s Why

Astrana Health, Inc. (NASDAQ:ASTH)’s stock price was down 2.7% during mid-day trading on Tuesday . The company traded as low as $32.58 and last traded at $32.58. Approximately 44,044 shares were traded during trading, a decline of 80% from the average daily volume of 217,443 shares. The stock had previously closed at $33.47.

Analyst Ratings Changes

A number of research analysts have issued reports on the company. KeyCorp assumed coverage on Astrana Health in a research report on Friday, October 11th. They set a “sector weight” rating for the company. BTIG Research increased their target price on Astrana Health from $60.00 to $70.00 and gave the company a “buy” rating in a report on Thursday, October 3rd. Macquarie raised Astrana Health to a “hold” rating in a research report on Monday, December 16th. TD Cowen initiated coverage on shares of Astrana Health in a research report on Monday, October 14th. They issued a “buy” rating and a $66.00 price target for the company. Finally, Robert W. Baird boosted their price objective on shares of Astrana Health from $67.00 to $86.00 and gave the company an “outperform” rating in a research report on Wednesday, November 13th. Two analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $65.17.

Astrana Health Stock Performance

The company has a quick ratio of 1.91, a current ratio of 1.91 and a debt-to-equity ratio of 0.60. The stock’s 50-day moving average price is $46.70 and its 200 day moving average price is $47.86. The company has a market cap of $1.88 billion, a P/E ratio of 25.75, a price-to-earnings-growth ratio of 1.80 and a beta of 1.14.

Astrana Health (NASDAQ:ASTH) last posted its quarterly earnings results on Thursday, November 7th. The company reported $0.33 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.33. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. The company had revenue of $478.71 million for the quarter, compared to analyst estimates of $462.01 million. During the same period last year, the business posted $0.47 EPS. As a group, research analysts expect that Astrana Health, Inc. will post 1.16 EPS for the current fiscal year.

Institutional Investors Weigh In On Astrana Health

A number of hedge funds and other institutional investors have recently bought and sold shares of ASTH. GAMMA Investing LLC bought a new position in shares of Astrana Health in the third quarter valued at about $34,000. Nisa Investment Advisors LLC acquired a new stake in shares of Astrana Health in the third quarter valued at approximately $35,000. KBC Group NV acquired a new position in Astrana Health during the 3rd quarter worth $70,000. Quarry LP bought a new position in Astrana Health in the 3rd quarter valued at $77,000. Finally, Quest Partners LLC bought a new stake in shares of Astrana Health during the third quarter worth $133,000. 52.77% of the stock is owned by institutional investors and hedge funds.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.